Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy: Is Metabolic Fear the Enemy of Logic? A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Rita JacobsWalter VerbruggheKarolien DamsElla RoelantMarie Madeleine CouttenyeDirk DevroeyPhilippe G JorensPublished in: Life (Basel, Switzerland) (2023)
regional citrate anticoagulation is a safe anticoagulant for critically ill patients who require CRRT, as no significant differences were found in metabolic complications between the groups. Additionally, citrate has a lower risk of bleeding and circuit loss than heparin.